NCT00686894View on ClinicalTrials.gov

Enthesitis With Ultra Sonography Doppler in Spondyloarthropathies Treated With Infliximab (Study P04440)

PHASE4TerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Spondylitis, AnkylosingSpA
Interventions
PROCEDURE

PDUS

PDUS scored for each enthesitis every 2 weeks for 24 weeks.

DRUG

Infliximab

"* 5 mg/kg~* IV~* Frequency : weeks 0,2,6"

Sponsors

Collaborators (1)

Centocor, Inc.
All Listed Sponsors
collaborator

Centocor, Inc.

INDUSTRY

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT00686894 - Enthesitis With Ultra Sonography Doppler in Spondyloarthropathies Treated With Infliximab (Study P04440) | Biotech Hunter | Biotech Hunter